# TOKAI

> TOKAI is a VC fund in Gifu backing Eyewear, Medical and Robotics. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Gifu, Japan
- Total investments: 4
- Last investment: Jul 2022
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.tokai-corp.com/

TOKAI is a VC fund in Gifu focused on Eyewear and Medical. TOKAI specializes in rental of dispensing pharmacies for hospital linen supplies and outsourcing of outsourced nursing care.

## Contacts

5 contacts available for TOKAI. Shizune tracks 1 team members at TOKAI. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tokai?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Eyewear | 1 | 25% |
| Medical | 1 | 25% |
| Robotics | 1 | 25% |
| Health Care | 1 | 25% |
| Manufacturing | 1 | 25% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 1 | 25% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 2 | 50% |
| Belgium | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Masahira Kawakami | Executive Officer | 1 | https://shizune.co/investors/profile/masahira-kawakami |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Morrow Optics | Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations.Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens.They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel.And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button.In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see. | $11M | Angel | Jul 18, 2022 |  |
| Morrow Optics | Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations.Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens.They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel.And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button.In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see. |  | Venture - Series Unknown | Jul 14, 2022 |  |
| INNOPHYS | INNOPHYS is developing, designing, manufacturing, consulting and distributing robotics equipment for various industries. Their flagship product, Muscle Suit® is a wearable robot supported by artificial muscle technology, well known for its high quality and reasonable price compared with the same kind of support exoskeletons. The company is planningto expand its business to Asia Pacific, Europe, and North America. | $496.1M | Series C | Dec 25, 2019 |  |
| CaTe | CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments. | $10.7M | Series B |  |  |

4 of 4 investments shown.

## Co-investors
- [ZEISS Group](https://shizune.co/investors/profile/carl-zeiss) — VC Fund, 2 deals together
- [imec.istart](https://shizune.co/investors/profile/imec-istart) — VC Fund, 2 deals together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 2 deals together
- [New Science Ventures](https://shizune.co/investors/profile/new-science-ventures) — VC Fund, 2 deals together
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund, 2 deals together
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

### Similar country
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund

## Featured in investor lists
- [Consumer Investors in Belgium](https://shizune.co/investors/consumer-investors-belgium)
- [Consumer VC Funds in Belgium](https://shizune.co/investors/consumer-vc-funds-belgium)
- [Marketplace Investors in Belgium](https://shizune.co/investors/marketplace-investors-belgium)
- [Marketplace VC Funds in Belgium](https://shizune.co/investors/marketplace-vc-funds-belgium)

## FAQ

### What does TOKAI invest in?

TOKAI invests primarily in Eyewear, Medical and Robotics startups, most often at Angel and Series B stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact TOKAI?

Public channels for TOKAI include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at TOKAI?

The team at TOKAI includes Masahira Kawakami (Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co